Physical activity, functional ability, and disease activity in children and adolescents with juvenile idiopathic arthritis

Abstract

Juvenile idiopathic arthritis (JIA) is a chronic condition known to cause pain-related complications in youth and affect children's physical functioning. There is no data in Arabic children with JIA about the impact of illness upon their physical activity. The objective of this study was to explore physical activity (PA) in children and adolescents with JIA compared with a healthy population and to examine associations between PA, functional ability, and disease activity. Our study included patients with JIA and group control aged between 8 and 17 years. The diagnosis was used according to the International League of Association of Rheumatology (ILAR) criteria 2001. Sociodemographic data and clinical features were collected. Physical activity level and energy expenditure were assessed with a 1-day activity diary and the metabolic equivalent (MET), respectively. Functional ability was assessed with the Moroccan version of the Childhood Health Assessment Questionnaire (CHAQ). Disease activity was measured using the Juvenile Arthritis Disease Activity Score (JADAS). Fifty patients and 50 controls were included (mean ± SD age 11.5 ± 3.3 and 10.5 ± 3.8 years, respectively; p = 0.49) with masculine predominance n = 30 (59.6 %) and n = 29 (58 %), respectively (p = 0.26). The median disease duration was 4.3 years (2-5). The median analog scale (VAS) pain was 20 (10-40). Fourteen patients (28 %) had an active disease. Patient population consisted in majority of oligoarticular arthritis (28 %), 14 patients. The mean of energy expenditure and physical activity were significantly higher in the JIA group. The JIA group spent more time in bed and less time on moderate to vigorous PA than the control group. There is no significant relationship between PA, functional ability, and disease activity. Our study suggests that children and adolescents with JIA have low PA levels and are at risk of losing the benefits of PA. Low PA is not related to functional ability, disease duration, and disease activity in children and adolescent with JIA. A large cohort is necessary to confirm these results.

Kardiovaskuläres Risiko und chronische Entzündung

“…Heranwachsende mit JIA können aufgrund von Schmerzen, Müdigkeit und Schlafstörungen, aber auch bedingt durch Muskelatrophie, Lungenfunktionsstörung und Anämie einem erhöhten Risiko für die Entwicklung eines sitzenden Lebensstils ausgesetzt sein [35,36]. Laut bisherigen Studien zeigen Kinder mit JIA eine verminderte körperliche Fitness [36][37][38], führen weniger anstrengende körperliche Aktivitäten durch [39][40][41] und verbringen mehr Zeit mit Schlafen als ihre gesunden Gleichaltrigen [42,43].…”

Bewegungs- und Sportberatung bei Kindern und Jugendlichen mit rheumatischen Erkrankungen

“…Dazu zählen z.B. der vorherrschende sitzende Lebensstil (14,16), Zeitmangel, Desinteresse oder räumliche Einschränkungen (23). Die Risiken für eine verzögerte motorische Entwicklung (1,18), eine abnehmende Lebensqualität (9,20) sowie Herz-Kreislauf-und Stoffwechselerkrankungen (8,12,17) nehmen durch eine anhaltende körperliche Inaktivität der jungen Patienten zu, welches langfristige Konsequenzen insbesondere im Erwachsenenalter haben kann (3,16).…”

“…In der dritten Phase, der Remissionsphase, ist bei den meisten Patienten eine uneingeschränkte Sportteilnahme möglich (1,2,29). Es gilt: viel Bewegung bei einer altersentsprechenden Belastung und Achtsamkeit (31), wobei funktionelle Einschränkungen vorab abgeklärt werden sollten und auf die richtige Technik bei der Durchführung zu achten ist (16,31).…”

Juvenile idiopathic arthritis and physical activity: Possible inflammatory and immune modulation and tracks for interventions in young populations

“…In healthy children and adolescents, physical activity is recognized as beneficial to normal growth and development, with a preservation of optimal metabolic function [9][10][11]. It has since emerged that exercise may have direct effects on the pathogenesis of autoimmune diseases by attenuating chronic low-grade systemic inflammation [8,12,13].…”